LLY vs ABBV Comparison
Compare financials and metrics between Eli Lilly and Company (LLY) and AbbVie Inc. (ABBV)
Stock Comparison
| Metric | LLY | ABBV |
|---|---|---|
| Market Cap | $838.5 B | $329.1 B |
| Gross Margin | 82% | 71% |
| Profit Margin | 33% | 0% |
| EBITDA margin | 45% | 4% |
| Quarterly Revenue | $13.5 B | $15.1 B |
| Quarterly Earnings | $4.4 B | -$22.0 M |
| Quarterly Free Cash Flow | $0 B | $6.8 M |
| Trailing 4 Quarters Revenue | $45.0 B | $56.3 B |
| Trailing 4 Quarters Earnings | $10.6 B | $4.3 B |
| Quarterly Earnings Growth | 101% | -103% |
| Annual Earnings Growth | 425% | -30% |
| Quarterly Revenue Growth | 45% | 6% |
| Annual Revenue Growth | 19% | 0% |
| Cash On Hand | $0 | $5.5 B |
| Short Term Debt | $0 | $6.8 B |
| Long Term Debt | $0 | $60.3 B |
| PE | 79.18 | 76.83 |
| PS | 18.62 | 5.84 |
| PB | 58.55 | 97.84 |
| PC | -1.00 | 59.58 |
| Liabilities to Equity | -1.00 | 39.64 |
| ROA | -100% | 3% |
| ROE | 74% | 129% |
| Current Ratio | 0.00 | 1.03 |
| Quick Ratio | -0.25 | 0.04 |
| Long Term Debt to Equity | 0.00 | 18.15 |
| Debt to Equity | 0.00 | 20.19 |
| Burn Rate | 0.00 | 1.34 |
| Cash to Cap | 0.00 | 0.02 |
| CCR | 0.00 | -307.14 |
| EV to EBITDA | 136.37 | 730.39 |
| EV to Revenue | 18.62 | 6.94 |